# 데이터셋 요약

|                         | 일반 수술 (n = 4,930) | 흉부 수술 (n = 1,111) | 부인과 (n = 230) | 비뇨기과 (n = 117) | 총계 (n = 6,388) |
|-------------------------|-----------------------|-----------------------|------------------|--------------------|-------------------|
| **인구 통계**           |                       |                       |                  |                    |                   |
| 성별 (남성)              | 2,524 (51.2%)         | 618 (55.6%)           | 0 (0%)           | 101 (86.3%)        | 3,243 (50.8%)     |
| 나이 (년)                | 59 (48-68)            | 61 (52-70)            | 45 (35-55)       | 64 (58-72)         | 59 (48-68)        |
| 키 (cm)                 | 162 (156-169)         | 163 (156-169)         | 159 (155-163)    | 168 (161-173)      | 162 (156-169)     |
| 체중 (kg)               | 60 (53-69)            | 61 (54-69)            | 59 (53-66)       | 69 (62-77)         | 61 (53-69)        |
| **수술 접근법**          |                       |                       |                  |                    |                   |
| 개복                    | 3,104 (63.0%)         | 190 (17.1%)           | 65 (28.3%)       | 6 (5.1%)           | 3,368 (52.7%)     |
| 비디오 내시경           | 1,691 (34.2%)         | 889 (80.0%)           | 140 (60.9%)      | 34 (29.1%)         | 2,701 (42.3%)     |
| 로봇                    | 135 (2.7%)            | 32 (2.9%)             | 25 (10.9%)       | 77 (65.8%)         | 269 (4.2%)        |
| **마취**                |                       |                       |                  |                    |                   |
| 전신 마취               | 4,630 (93.9%)         | 1,093 (98.4%)         | 203 (88.3%)      | 117 (100.0%)       | 6,043 (94.6%)     |
| 척추 마취               | 246 (5.0%)            | 0 (0.0%)              | 27 (11.7%)       | 0 (0.0%)           | 273 (4.3%)        |
| 진정                   | 54 (1.1%)             | 18 (1.6%)             | 0 (0.0%)         | 0 (0.0%)           | 72 (1.1%)         |
| **마취 시간 (분)**       | 150 (90-245)          | 170 (110-220)         | 135 (95-185)     | 190 (79-231)       | 150 (90-240)      |
| **마취제**              |                       |                       |                  |                    |                   |
| 세보플루란              | 2,076 (42.1%)         | 255 (23.0%)           | 172 (74.8%)      | 34 (29.1%)         | 2,537 (39.7%)     |
| 데스플루란              | 1,012 (20.5%)         | 226 (20.3%)           | 69 (30.0%)       | 106 (90.6%)        | 1,383 (21.6%)     |
| 프로포폴 TCI           | 2,490 (50.5%)         | 996 (89.6%)           | 5 (2.2%)         | 7 (6.0%)           | 3,498 (54.8%)     |
| 레미펜타닐 TCI         | 3,639 (73.8%)         | 1,000 (90.0%)         | 110 (47.8%)      | 86 (73.5%)         | 4,835 (75.7%)     |
| **장치**                |                       |                       |                  |                    |                   |
| Tram-Rac 4A (SNUADC)   | 4,910 (99.6%)         | 1,103 (99.3%)         | 226 (98.3%)      | 116 (99.1%)        | 6,355 (99.5%)     |
| Solar 8000M            | 4,930 (100.0%)        | 1,111 (100.0%)        | 230 (100.0%)     | 117 (100.0%)       | 6,388 (100%)      |
| Primus                 | 4,915 (99.7%)         | 1,104 (99.4%)         | 226 (98.3%)      | 117 (100.0%)       | 6,362 (99.6%)     |
| BIS Vista              | 4,282 (86.9%)         | 1,004 (90.4%)         | 196 (85.2%)      | 84 (71.8%)         | 5,566 (87.1%)     |
| Orchestra              | 3,713 (75.3%)         | 1,005 (90.5%)         | 115 (50.0%)      | 86 (73.5%)         | 4,919 (77.0%)     |
| Vigileo                | 85 (1.7%)             | 227 (20.4%)           | 4 (1.7%)         | 32 (27.4%)         | 348 (5.4%)        |
| EV1000                 | 598 (12.1%)           | 1 (0.1%)              | 0 (0.0%)         | 0 (0.0%)           | 599 (9.4%)        |
| Vigilance II           | 63 (1.3%)             | 0 (0.0%)              | 0 (0.0%)         | 0 (0.0%)           | 63 (1.0%)         |
| CardioQ                | 29 (0.6%)             | 0 (0.0%)              | 0 (0.0%)         | 0 (0.0%)           | 29 (0.5%)         |
| INVOSTM                | 33 (0.7%)             | 0 (0.0%)              | 0 (0.0%)         | 0 (0.0%)           | 33 (0.5%)         |
| FMS2000                | 15 (0.3%)             | 0 (0.0%)              | 0 (0.0%)         | 0 (0.0%)           | 15 (0.2%)         |